Literature DB >> 6468488

Level of verapamil in human milk.

H Inoue, N Unno, M C Ou, Y Iwama, T Sugimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6468488     DOI： 10.1007/BF00543507

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Determination of verapamil in human plasma by mass fragmentography using stable isotope-labelled verapamil as internal standard.

Authors:  B Spiegelhalder; M Eichelbaum
Journal:  Arzneimittelforschung       Date:  1977

2.  Level of verapamil in human milk.

Authors:  H Inoue; N Unno; M C Ou; Y Iwama; T Sugimoto
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Excretion of verapamil in human milk.

Authors:  H J Andersen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
  3 in total
  10 in total

1.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Level of verapamil in human milk.

Authors:  H Inoue; N Unno; M C Ou; Y Iwama; T Sugimoto
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

4.  An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.

Authors:  Ehsan Sohrabi; Ehsan Rezaie; Mohammad Heiat; Yousef Sefidi-Heris
Journal:  Biochem Genet       Date:  2021-04-03       Impact factor: 1.890

5.  Verapamil and norverapamil in plasma and breast milk during breast feeding.

Authors:  P Anderson; U Bondesson; I Mattiasson; B W Johansson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 6.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

Review 7.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 8.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

9.  Verapamil and breast-feeding.

Authors:  M R Miller; R Withers; R Bhamra; D W Holt
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer.

Authors:  Yuan Chen; Ruiyuan Xu; Rexiati Ruze; Jinshou Yang; Huanyu Wang; Jianlu Song; Lei You; Chengcheng Wang; Yupei Zhao
Journal:  Cancer Cell Int       Date:  2021-06-05       Impact factor: 5.722
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.